Tangible Shareholders Equity: The value shareholders equity less intangible assets.
XORTX Therapeutics Inc. (XRTX) had Tangible Shareholders Equity of $3.15M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-3.31M |
|
-- |
|
-- |
|
$4.12M |
|
$-4.12M |
|
$0.81M |
|
$-3.31M |
|
$-3.31M |
|
$-3.31M |
|
$-3.31M |
|
$-3.31M |
|
$-3.31M |
|
$-4.12M |
|
$-4.00M |
|
2.88M |
|
2.88M |
|
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$2.68M |
|
$0.03M |
|
$1.42M |
|
$4.09M |
|
$0.76M |
|
-- |
|
-- |
|
$0.76M |
|
$3.34M |
|
|
Tangible Shareholders Equity |
$3.15M |
$3.34M |
|
3.48M |
|
| Cash Flow Statement Financials | |
$-3.68M |
|
$-0.04M |
|
$2.78M |
|
$3.45M |
|
$2.47M |
|
$-0.97M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|